Eton Pharmaceuticals, Inc. (ETON)
25.04
+0.61
(+2.50%)
USD |
NASDAQ |
Apr 17, 16:00
25.01
-0.03
(-0.12%)
After-Hours: 20:00
Eton Pharmaceuticals Cash from Investing (Quarterly) : -0.049M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -11.84M |
| Amicus Therapeutics, Inc. | -6.494M |
| Ovid Therapeutics, Inc. | -72.06M |
| Rhythm Pharmaceuticals, Inc. | 30.35M |
| Vir Biotechnology, Inc. | 86.65M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.55M |
| Cash from Financing (Quarterly) | 0.421M |
| Free Cash Flow | 10.19M |
| Free Cash Flow Per Share (Quarterly) | -0.3713 |
| Free Cash Flow to Equity (Quarterly) | -11.81M |
| Free Cash Flow to Firm (Quarterly) | -10.33M |
| Free Cash Flow Yield | 1.45% |